Labaru

Kaisariya, Isra'ila, 13 ga Yuni, 2022 / prNewswire / - Icecure Medicar Ltd. (NasdaQ:) ICCM), Ltd. ("IceCure) ko kuma ICCIure" Medtech Co., Ltd. Shanghai " Ana sa ran za a isar da tsarin kankara a cikin 2022.
Medtronic Shanghai za ta zama matattarar dindindin na dusar ƙanƙara3 da kuma zubar da binciken a cikin babban shekaru uku, tare da mafi karancin sayan $ 3.5 miliyan a wannan lokacin. Bugu da kari, a cikin yankin China, da Shanghai Medtronic ba zai sanya hannun jari kai tsaye ko kasuwanci ba, kasuwa, kasuwa ta inganta tare da Icesense3 a lokacin da ya wuce watanni shida (6) watanni. Kudin zai kasance da alhakin shigo da shi, shigarwa da sabis na tallace-tallace na Iceseense3 tsarin da China Shanghai zai rike duk tallan, tallace-tallace da wasu horarwa.
Gwamnatin Kayan Icesense3 na Icesense3 na Icesene3 ("NMPTA"). Icecure ya yi amfani da tsarin takardar shaidar rajista don amincewa da zaɓin ƙwayoyin cuta, idan an yarda da shi, zai ba da damar karɓar yardar NMPA a ƙarshen ƙarshen 2022.
"Shanghai Medtronic da kuma turawa suna da kyau abokan tarayya a gare mu a garin Sin, inda shigar da shigarwar keke na tallan masana'antu a halin yanzu. Mun ga kyakkyawan damar don yaduwar yaduwar Icesensea na Icesensee3 a cikin tsarin Cryoablation mu a cikin yankin China, kasuwa wacce take girma da sauri. CEWA ingancin Camie Eyal Shamir. "A matsayinka na kamfanin nimindin na'urar na duniya, Shanghai Medtronic yana da kwarewa da ikon kasuwa don samar da lafiya, ingantaccen magani don farkon cutar kansa da kuma wasu alamomi."
Jing Yu, Mataimakin Shugaban Kasa na Duniya da Mataimakin Janar Tabarinar Tabarma Haɗin gwiwa tare da Idecid da Turawa za su daidaita layin samfurin Shanghai na Medtronic a cikin Orcology Neurgenery. Muna fatan wannan haɗin gwiwar zai ci gaba da aikace-aikacen Clinication kuma mu amfana da yawan masu cutar ƙwayar cuta, kuma muna fatan yin aiki tare da ƙarin ƙwararrun likita. Kiwon lafiya na kasar Sin.
Neman Shugaba Lin Youjia, "A cikin Haɗin kai tare da hadin kai tare da ICCEure, mun kuduri don fara tura hannu da saurin saitin Icese3 tsarin a yankin China. Kasancewarmu a cikin ƙasar Sin tana tabbatar da Cibiyoyin Media sun sami babban tallafin fasaha da sabis ɗin yana amfani da tsarin dusar kankara na dogon lokaci. "
A ranar 12 ga Yuni, 2022 ("ranar tasiri"), Icecure Shanghai ya shiga cikin tallace-tallace na musamman da yarjejeniya da Icessenic da kuma zubar da kaya ("samfurori") don lokacin farko. Watanni 36, mafi karancin sayan maƙasudin wannan lokacin shine $ 3.5 miliyan ("Mafi qarancin Siyarwa"). A karkashin yarjejeniyar rarraba, ICECure Shanghai zai sayar da samfuran Turawa da turawa zai shigo da kayayyakin shigo da kayayyaki zuwa yankin China da kuma sake raba su zuwa Medtronic Shanghai Shanghai. Medtronic ShangHai za ta kasance da alhakin, a tsakanin wasu abubuwa: (i) Kasuwanci da Inganta samfurin a yankin China; (ii) Gudanar da ayyukan ilimin likita na kwararru don samfurin a cikin yankin China. Nearfafa zai dauki alhakin wariyar wajan, dabaru, garanti, horo da sauran tallafi da sabis na bayan tallace-tallace.
A karkashin sharuddan Yarjejeniyar Yarjejeniya, Shanghai Medtronic yana da hakkin tsawaita lokacin da aka rarraba shekaru uku idan ya kai matakin da aka sayo sayan sayan. Za'a iya dakatar da Yarjejeniyar Yarjejeniyar a karkashin wasu yanayi, gami da a lokacin taron wani tsoho, tsoho na zamani ko insolvency.
Bugu da kari, batun da sharuddan Yarjejeniyar Mahalli, Iccure Shanghai zai zama da alhakin samun da kuma kiyaye duk wani karatuna, inganta shigarwa, inganta, sayar da tsari, sayar da kuma amfani da samfuran a yankin China. NMPTA, reshe na gida, ko kuma wata hukuma ta gwamnati ("tsaftataccen ikon"). Icecure Shanghai ya samu amincewar da Icesense3 na wayar kankara kuma yana buƙatar amincewa da ƙa'idodi don hanyoyin fasahar Icesense3 cikin watanni tara daga ingantacciyar ranar Yarjejeniyar Yarjejeniya. Shanghai Medtronic yana da 'yancin dakatar da Yarjejeniyar Rarraba idan ICCure Shanghai ba ya karbi amincewar tsari don copprrobes a lokacin.
ICCure likita (nasdaq: ICCM) (Tase: ICCM) yana haɓaka da kasuwanni masu ɗaukar hoto na nitrogen, da farko suna niyya nono, koda, masu cutar sankarau. crayfish. Fasahar da ta fi yawa tana samar da aminci da ingantaccen madadin cututtukan cututtukan cututtukan fata ta cire, tare da gajeriyar aiki da kuma saurin aiki. Har zuwa yau, an tallata tsarin kuma a duniya ta duniya ta FDA ta tabbatar da alamar CE CE a Turai.
Wannan sakin mai yayyad da ya ƙunshi bayanan neman ci gaba a cikin ma'anar "Gidan Harbor" na Dokar Grantorm na Gratorm na 1995 da sauran dokokin tsaro na tarayya. Kalmomi irin su "tsammani", "Tsammani", "Shirin" da makamantansu "da kuma irin waɗannan kalmomin an yi nufin yin magana da maganganu na gaba. Misali, Idicure yana amfani da maganganun da ke gaba a cikin wannan sanarwar yayin da ake tattaunawa da Yarjejeniyar rarrabuwar kawuna tare da damar kasuwanci, da damar kasuwancin kamfanin a cikin yankin China. Saboda irin waɗannan bayanan suna da alaƙa da abubuwan da suka faru nan gaba kuma suna da alaƙa da gaskiyar yanayin yanayin, da kuma nasarorin da maganganun na iya bambanta da waɗanda aka bayyana ko kuma abubuwan da aka ambata a cikin wannan sanannun. Akwai bambance-bambance masu mahimmanci. . Bayanan binciken gaba suna dauke da ko wanda aka ambata a cikin wannan yakin jaridu suna ƙarƙashin sauran haɗari da rashin tabbas a cikin secter 20, 2022, ana bayyana su a gidan yanar gizon Sec 31, 2022, ana bayyana su akan gidan yanar gizon Sec 31, 2022, ana bayyana su akan gidan yanar gizon Sec a www.sec.gov. Kamfanin ba ya gudanar da wani takalifi don sabunta waɗannan maganganun don bita ko canje-canje bayan ranar wannan sakewa, sai dai in da bukatar yin hakan ta hanyar doka.